Investment Q&A

• Theratechnologies Inc. (TH $4.47)
  • $4.47 Cap: $205M
  • View TH Profile
  • View Questions on TH

Q: Please comment on latest earnings and provide your opinion on this company's outlook. Thanks.

Upvote 0

Read Answer Asked by Ray on February 25, 2022

• Amgen Inc. (AMGN $349.53)
  • $349.53 P/E (TTM): 25.38X Cap: $189.47B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $734.87)
  • $734.87 P/E (TTM): 18.3X Cap: $78.66B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $450.30)
  • $450.30 P/E (TTM): 30.25X Cap: $114.71B
  • View VRTX Profile
  • View Questions on VRTX
• Mettler-Toledo International Inc. (MTD $1,181.31)
  • $1,181.31 P/E (TTM): 28.64X Cap: $24.21B
  • View MTD Profile
  • View Questions on MTD

Q: I'm hearing that pharma and biotech company valuations are at multi year lows. With one chart showing the percentage of US biotechs with market caps below cash value is at a 25 year high, and by a wide margin. Do you feel this sector shows a big opportunity to get good companies for cheap in a sector that will one day improve? If so what companies look best to you in Canada or US? Are there any sectors that are more beaten up? Thx

Upvote 0

Read Answer Asked by Adam on February 23, 2022

• Teladoc Health Inc. (TDOC $5.45)
  • $5.45 Cap: $966M
  • View TDOC Profile
  • View Questions on TDOC

Q: There earning came out yesterday,please analysis.Is there any chance of getting back some what where it was in 2 3 yrs?
tnx u.....

Upvote 0

Read Answer Asked by tom on February 23, 2022

• Hamilton Thorne Ltd. (HTL $2.24)
  • View HTL Profile
  • View Questions on HTL

Q: Please comment on HTL's Q4 and 2021 results released today.

Upvote 0

Read Answer Asked by John on February 18, 2022

• Knight Therapeutics Inc. (GUD $6.35)
  • $6.35 Cap: $615M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Thanks for the prompt reply. What were the sales for the previous two quarters?

Upvote 0

Read Answer Asked by Steven on February 17, 2022

• Knight Therapeutics Inc. (GUD $6.35)
  • $6.35 Cap: $615M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Do you have an imminent quarterly reporting date for Knight and any results expectations would be appreciated. Thank you.

Upvote 0

Read Answer Asked by Steven on February 17, 2022

• Quipt Home Medical Corp. (QIPT $4.98)
  • $4.98 Cap: $220M
  • View QIPT Profile
  • View Questions on QIPT

Q: What is your take on the quarter? Is the company on a cash burn rate or generating free cashflow if you normalize or remove acquisitions? Thanks

Upvote 0

Read Answer Asked by Scott on February 17, 2022

• Jamieson Wellness Inc. (JWEL $33.14)
  • $33.14 P/E (TTM): 23.65X Cap: $1.41B
  • View JWEL Profile
  • View Questions on JWEL

Q: YOUR CURRENT OPINION ON JAMIESON WELLNES

Upvote 0

Read Answer Asked by Karen on February 16, 2022

• Neighbourly Pharmacy Inc. (NBLY $18.60)
  • View NBLY Profile
  • View Questions on NBLY

Q: Hi,

Could you comment on NBLY’s earnings? How did they do vs analyst expectations?

Thanks
Peter

Upvote 0

Read Answer Asked by Peter on February 16, 2022

• 1Life Healthcare Inc. (ONEM)
  • View ONEM Profile
  • View Questions on ONEM

Q: Hello,
Can I get an update on 1 Life Healthcare. Would you buy at these levels? Can I get one alternative healthcare stock that you would recommend instead. Investment horizon is 3-5 years.
Thank-you.

Upvote 0

Read Answer Asked by Antonio on February 16, 2022

• Reliq Health Technologies Inc. (RHT)
  • Cap: $47M
  • View RHT Profile
  • View Questions on RHT

Q: Can you please give an update on RHT. Would you consider it a buy, sell or hold at these levels.

Upvote 0

Read Answer Asked by Bruce on February 15, 2022

• Veeva Systems Inc. Class A (VEEV $185.47)
  • $185.47 P/E (TTM): 36.39X Cap: $30.25B
  • View VEEV Profile
  • View Questions on VEEV
• WELL Health Technologies Corp. (WELL $4.14)
  • $4.14 Cap: $1.06B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: WELL or VEEV, which stock has the most upside potential? High risk tolerance.

Thanks for your service!

Upvote 0

Read Answer Asked by Ozzie on February 15, 2022

• Veradigm Inc. (MDRX $4.60)
  • $4.60 Cap: $503M
  • View MDRX Profile
  • View Questions on MDRX

Q: Hello 5i,
Could I have your assessment of MDRX please? Would you be a buyer today?
Thank you
Dave

Upvote 0

Read Answer Asked by Dave on February 15, 2022

• Trulieve Cannabis Corp (TRUL $8.49)
  • $8.49 Cap: $1.63B
  • View TRUL Profile
  • View Questions on TRUL
• Verano Holdings Corp. Subordinate Voting Shares (VRNO)
  • Cap: $2.17B
  • View VRNO Profile
  • View Questions on VRNO

Q: Cannabis seems to have turned the corner and has had some good recent momentum. Do you see this as an opportunity in 2022 and beyond. Would you be buyers of Trul & Vrno at these prices?

Upvote 0

Read Answer Asked by Chris on February 15, 2022

• Amgen Inc. (AMGN $349.53)
  • $349.53 P/E (TTM): 25.38X Cap: $189.47B
  • View AMGN Profile
  • View Questions on AMGN
• AbbVie Inc. (ABBV $207.36)
  • $207.36 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Freeport-McMoRan Inc. (FCX $52.83)
  • $52.83 P/E (TTM): 38.22X Cap: $79.69B
  • View FCX Profile
  • View Questions on FCX
• Merck & Company Inc. (MRK $114.08)
  • $114.08 P/E (TTM): 15.92X Cap: $283.08B
  • View MRK Profile
  • View Questions on MRK
• Pfizer Inc. (PFE $27.33)
  • $27.33 P/E (TTM): 20.18X Cap: $155.40B
  • View PFE Profile
  • View Questions on PFE
• Roper Technologies Inc. (ROP $351.92)
  • $351.92 P/E (TTM): 24.85X Cap: $36.10B
  • View ROP Profile
  • View Questions on ROP
• Royal Bank of Canada (RY $219.94)
  • $219.94 P/E (TTM): 15.08X Cap: $311.35B
  • View RY Profile
  • View Questions on RY
• Toronto-Dominion Bank (The) (TD $128.04)
  • $128.04 P/E (TTM): 10.52X Cap: $216.13B
  • View TD Profile
  • View Questions on TD
• Bank of Nova Scotia (The) (BNS $93.95)
  • $93.95 P/E (TTM): 23.63X Cap: $118.13B
  • View BNS Profile
  • View Questions on BNS
  • View Reports on BNS
• Bank of Montreal (BMO $186.89)
  • $186.89 P/E (TTM): 15.09X Cap: $133.65B
  • View BMO Profile
  • View Questions on BMO
• Manulife Financial Corporation (MFC $46.50)
  • $46.50 P/E (TTM): 15.56X Cap: $78.89B
  • View MFC Profile
  • View Questions on MFC
• Canadian Imperial Bank Of Commerce (CM $130.82)
  • $130.82 P/E (TTM): 13.95X Cap: $122B
  • View CM Profile
  • View Questions on CM
• Sun Life Financial Inc. (SLF $85.80)
  • $85.80 P/E (TTM): 14.26X Cap: $48.19B
  • View SLF Profile
  • View Questions on SLF
  • View Reports on SLF
• Constellation Software Inc. (CSU $2,490.10)
  • $2,490.10 P/E (TTM): 78.8X Cap: $54.41B
  • View CSU Profile
  • View Questions on CSU
  • View Reports on CSU
• Tourmaline Oil Corp. (TOU $69.36)
  • $69.36 P/E (TTM): 92.78X Cap: $25.97B
  • View TOU Profile
  • View Questions on TOU
• WSP Global Inc. (WSP $217.39)
  • $217.39 P/E (TTM): 30.24X Cap: $29.90B
  • View WSP Profile
  • View Questions on WSP
  • View Reports on WSP
• Canadian Apartment Properties Real Estate Investment Trust (CAR.UN $35.92)
  • $35.92 P/E (TTM): 28.48X Cap: $5.53B
  • View CAR.UN Profile
  • View Questions on CAR.UN
• TFI International Inc. (TFII $135.01)
  • $135.01 P/E (TTM): 35.65X Cap: $11.35B
  • View TFII Profile
  • View Questions on TFII
  • View Reports on TFII
• ATS Corporation (ATS $42.28)
  • $42.28 Cap: $4.28B
  • View ATS Profile
  • View Questions on ATS
  • View Reports on ATS
• Granite Real Estate Investment Trust (GRT.UN $82.73)
  • $82.73 Cap: $5.21B
  • View GRT.UN Profile
  • View Questions on GRT.UN
• Tamarack Valley Energy Ltd. (TVE $11.18)
  • $11.18 Cap: $5.30B
  • View TVE Profile
  • View Questions on TVE
• Dream Industrial Real Estate Investment Trust (DIR.UN $12.57)
  • $12.57 P/E (TTM): 35.27X Cap: $3.78B
  • View DIR.UN Profile
  • View Questions on DIR.UN
  • View Reports on DIR.UN
• Profound Medical Corp. (PRN $7.22)
  • $7.22 Cap: $227M
  • View PRN Profile
  • View Questions on PRN
• Nutrien Ltd. (NTR $105.16)
  • $105.16 P/E (TTM): 36.77X Cap: $51.70B
  • View NTR Profile
  • View Questions on NTR
• NV5 Global Inc. (NVEE $22.56)
  • $22.56 P/E (TTM): 49.04X Cap: $1.48B
  • View NVEE Profile
  • View Questions on NVEE
• Digital Turbine Inc. (APPS $3.31)
  • $3.31 Cap: $390M
  • View APPS Profile
  • View Questions on APPS
• Jacobs Solutions Inc. (J $127.37)
  • $127.37 P/E (TTM): 36.22X Cap: $15B
  • View J Profile
  • View Questions on J
• Topicus.com Inc. (TOI $96.31)
  • $96.31 P/E (TTM): 308.43X Cap: $12.58B
  • View TOI Profile
  • View Questions on TOI
  • View Reports on TOI
• TELUS International (Cda) Inc. Subordinate Voting Shares (TIXT $6.07)
  • $6.07 Cap: $1.68B
  • View TIXT Profile
  • View Questions on TIXT
  • View Reports on TIXT
• Neighbourly Pharmacy Inc. (NBLY $18.60)
  • View NBLY Profile
  • View Questions on NBLY

Q: Hi group - I am a medium risk investor - Can you please give me your top picks + % weighting in the top sectors - Financial, Industrials, Materials , Energy, Health care , real estate, Tech Thanks

Upvote 0

Read Answer Asked by Terence on February 14, 2022

• Savaria Corporation (SIS $25.35)
  • $25.35 P/E (TTM): 29.86X Cap: $5.81B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: thoughts on the news from SIS today?


Thx

Upvote 0

Read Answer Asked by blake on February 10, 2022

• Veeva Systems Inc. Class A (VEEV $185.47)
  • $185.47 P/E (TTM): 36.39X Cap: $30.25B
  • View VEEV Profile
  • View Questions on VEEV
• Repligen Corporation (RGEN $117.37)
  • $117.37 P/E (TTM): 138.69X Cap: $6.62B
  • View RGEN Profile
  • View Questions on RGEN

Q: Hello 5i
I have owned RGEN for several years.
Could you tell me how you would rank it against its peers? Is there a name you prefer more and if so why?
Thank you so much!!
Dave

Upvote 0

Read Answer Asked by Dave on February 10, 2022

• Zimmer Biomet Holdings Inc. (ZBH $89.99)
  • $89.99 P/E (TTM): 26.06X Cap: $17.42B
  • View ZBH Profile
  • View Questions on ZBH

Q: Good morning, Peter & 5 i team

Will Zimmer spin off have positive effect on its share price and future growth? If you must choose 1 of the 2, would you choose Zim Vie over Zimmer Biomet?

Thank you and have a good day!

Upvote 0

Read Answer Asked by Nhung on February 09, 2022

• Neighbourly Pharmacy Inc. (NBLY $18.60)
  • View NBLY Profile
  • View Questions on NBLY

Q: I'm trying to understand NBLY .... For starters it is a chain of drug stores that is losing money ... Why ? ..... And second what is the hook here ? I understand the format of Shoppers ..... Flyers, weekly sales, and appear to be a grocery and makeup store more than a pharmacy . What is the format in a Neighbourly Pharmacy when one enters the door ? Is it a pure pharmacy ? ...... Are there other products sold ? .....What does the corporate structure offer to these places ? What is your opinion on management ? ......Please explain what the attraction is here ? Thanks Garth

Upvote 0

Read Answer Asked by Garth on February 08, 2022

• AbbVie Inc. (ABBV $207.36)
  • $207.36 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Danaher Corporation (DHR $188.84)
  • $188.84 P/E (TTM): 19.33X Cap: $135.41B
  • View DHR Profile
  • View Questions on DHR
• Eli Lilly and Company (LLY $918.01)
  • $918.01 P/E (TTM): 40.54X Cap: $867.39B
  • View LLY Profile
  • View Questions on LLY
• Merck & Company Inc. (MRK $114.08)
  • $114.08 P/E (TTM): 15.92X Cap: $283.08B
  • View MRK Profile
  • View Questions on MRK
• Pfizer Inc. (PFE $27.33)
  • $27.33 P/E (TTM): 20.18X Cap: $155.40B
  • View PFE Profile
  • View Questions on PFE

Q: I currently hold Abbvie and PFE in our portfolio. I'm looking to add another in the healthcare sector, such as Eli Lily, Merck or Danaher. Do you have a preference among thee to add or another?

Upvote 0

Read Answer Asked by Gerry on February 08, 2022